Kelly Metcalfe
#75,596
Most Influential Person Now
Canadian scientist, professor at the University of Toronto and at Women's College Hospital, Canada
Kelly Metcalfe's AcademicInfluence.com Rankings
Kelly Metcalfephilosophy Degrees
Philosophy
#10984
World Rank
#15083
Historical Rank
Logic
#8791
World Rank
#11047
Historical Rank
Download Badge
Philosophy
Why Is Kelly Metcalfe Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kelly A. Metcalfe is a Canadian scientist and a professor at the University of Toronto and at Women's College Hospital. Her work's focus is on understanding the clinical and psychosocial implications of genetic testing for BRCA gene mutations in women, men and their families.
Kelly Metcalfe's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. (2004) (624)
- Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. (2014) (506)
- International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers (2008) (336)
- Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer (2004) (283)
- Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis (2014) (246)
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. (2019) (196)
- A Comparison of Psychological Response, Body Image, Sexuality, and Quality of Life between Immediate and Delayed Autologous Tissue Breast Reconstruction: A Prospective Long-Term Outcome Study (2016) (185)
- Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. (2008) (182)
- Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. (2010) (173)
- The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation. (2011) (173)
- Using a Mobile App for Monitoring Post-Operative Quality of Recovery of Patients at Home: A Feasibility Study (2015) (172)
- Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2017) (171)
- The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers. (2005) (151)
- Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy (2004) (127)
- Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1‐related breast carcinoma (2003) (125)
- Changes in Psychosocial Functioning 1 Year After Mastectomy Alone, Delayed Breast Reconstruction, or Immediate Breast Reconstruction (2011) (114)
- Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. (2010) (113)
- An evaluation of needs of female BRCA1and BRCA2 carriers undergoing genetic counselling (2000) (105)
- Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. (2015) (104)
- Long-Term Psychosocial Functioning in Women with Bilateral Prophylactic Mastectomy: Does Preservation of the Nipple-Areolar Complex Make a Difference? (2015) (96)
- The impact of prophylactic salpingo‐oophorectomy on quality of life and psychological distress in women with a BRCA mutation (2013) (90)
- Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. (2011) (85)
- Risk of ipsilateral breast cancer in BRCA1 and BRCA2 mutation carriers (2011) (85)
- Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. (2006) (84)
- Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. (2002) (83)
- The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation (2005) (80)
- International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation (2019) (78)
- Decision Regret following Breast Reconstruction: The Role of Self-Efficacy and Satisfaction with Information in the Preoperative Period (2013) (75)
- Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening (2012) (75)
- A multicenter study of supportive‐expressive group therapy for women with BRCA1/BRCA2 mutations (2004) (67)
- Next-Generation Service Delivery: A Scoping Review of Patient Outcomes Associated with Alternative Models of Genetic Counseling and Genetic Testing for Hereditary Cancer (2018) (64)
- The BRCA Self‐Concept Scale: a new instrument to measure self‐concept in BRCA1/2 mutation carriers (2009) (60)
- Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study. (2009) (55)
- Time to reconsider subcutaneous mastectomy for breast-cancer prevention? (2005) (54)
- Pre-consultation educational group intervention to improve shared decision-making for postmastectomy breast reconstruction: a pilot randomized controlled trial (2015) (49)
- A Comparison of Bilateral Breast Cancers in BRCA Carriers (2005) (46)
- Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation (2007) (42)
- Feasibility, acceptability and effects of a foot self-care educational intervention on minor foot problems in adult patients with diabetes at low risk for foot ulceration: a pilot study. (2013) (40)
- Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial (2016) (39)
- Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer (2011) (39)
- Predictors of Quality of Life in Women with a Bilateral Prophylactic Mastectomy (2005) (34)
- A prospective study of mastectomy patients with and without delayed breast reconstruction: Long‐term psychosocial functioning in the breast cancer survivorship period (2015) (34)
- Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. (2004) (34)
- Improving Foot Self-Care Knowledge, Self-Efficacy, and Behaviors in Patients With type 2 Diabetes at Low Risk for Foot Ulceration (2014) (34)
- Should all BRCA1 mutation carriers with stage I breast cancer receive chemotherapy? (2013) (33)
- Revisiting breast cancer patients who previously tested negative for BRCA mutations using a 12-gene panel (2016) (33)
- International Rates of Breast Reconstruction After Prophylactic Mastectomy in BRCA1 and BRCA2 Mutation Carriers (2013) (33)
- Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. (2019) (33)
- The impact of having a sister diagnosed with breast cancer on cancer‐related distress and breast cancer risk perception (2013) (32)
- Development of patients' decision aid for older women with stage I breast cancer considering radiotherapy after lumpectomy. (2012) (31)
- Direct-to-patient BRCA1 testing: the Twoj Styl experience (2006) (30)
- Using Propensity Score Analysis to Compare Major Complications between DIEP and Free Muscle-Sparing TRAM Flap Breast Reconstructions (2014) (29)
- Prophylactic bilateral mastectomy (2002) (28)
- Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation (2016) (26)
- The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study (2016) (26)
- Identification of patients at high risk of psychological distress after BRCA1 genetic testing. (2009) (25)
- Preferences for breast cancer risk reduction among BRCA1/BRCA2 mutation carriers: a discrete-choice experiment (2017) (24)
- A patient decision aid for antidepressant use in pregnancy: study protocol for a randomized controlled trial (2016) (23)
- MRI Volumetric Analysis of Breast Fibroglandular Tissue to Assess Risk of the Spared Nipple in BRCA1 and BRCA2 Mutation Carriers (2014) (22)
- Prophylactic bilateral mastectomy for breast cancer prevention. (2004) (20)
- Bilateral Mastectomy in Women With Unilateral Breast Cancer: A Review. (2021) (20)
- The influence of dispositional optimism on decision regret to undergo major breast reconstructive surgery (2013) (20)
- Breast and ovarian cancer risk perception after prophylactic salpingo‐oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene (2009) (20)
- Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (2019) (19)
- Uptake of Preimplantation Genetic Diagnosis in Female BRCA1 and BRCA2 Mutation Carriers (2018) (19)
- An evaluation of oncofertility decision support resources among breast cancer patients and health care providers (2019) (18)
- A Breast Reconstruction Needs Assessment: How does Self-Efficacy Affect Information Access and Preferences? (2012) (18)
- Oophorectomy for Breast Cancer Prevention in Women with Brca1 Or Brca2 Mutations (2009) (18)
- The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients (2019) (17)
- Predictors of long-term cancer-related distress among female BRCA1 and BRCA2 mutation carriers without a cancer diagnosis: an international analysis (2020) (17)
- Is it time to offer BRCA1 and BRCA2 testing to all Jewish women? (2015) (16)
- A family with three germline mutations in BRCAl and BRCA2 (1998) (16)
- A patient decision aid for antidepressant use in pregnancy: Pilot randomized controlled trial. (2019) (14)
- Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’ (2014) (14)
- Development and testing of a decision aid for women considering delayed breast reconstruction. (2017) (13)
- Psychosocial Functioning in Women with Early Breast Cancer Treated with Breast Surgery With or Without Immediate Breast Reconstruction (2019) (11)
- Pre-consultation educational group intervention to improve shared decision-making in postmastectomy breast reconstruction: study protocol for a pilot randomized controlled trial (2013) (11)
- Predictors of uptake of contralateral prophylactic mastectomy in women with nonhereditary breast cancer (2019) (11)
- Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer (2021) (10)
- Examining the dimensionality of the Fear of Cancer Recurrence Inventory (2018) (10)
- Year 1: Experiences of a tertiary cancer centre following implementation of reflex BRCA1 and BRCA2 tumor testing for all high-grade serous ovarian cancers in a universal healthcare system. (2020) (10)
- Variation in Rates of Uptake of Preventive Options in BRCA1 and BRCA2 Mutation Carriers Across Canada (2007) (9)
- Why Some Mastectomy Patients Opt to Undergo Delayed Breast Reconstruction: Results of a Long-Term Prospective Study (2017) (9)
- Breast cancer prevention in women with a BRCA1 or BRCA2 mutation (2007) (8)
- Psychosocial Interventions for Women with a BRCA1 or BRCA2 Mutation: A Scoping Review (2021) (8)
- Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result (2021) (7)
- Development of a patient decision aid for people with refractory angina: protocol for a three-phase pilot study (2014) (7)
- Decision aids available for parents making end‐of‐life or palliative care decisions for children: A scoping review (2020) (7)
- Does the age of breast cancer diagnosis in first-degree relatives impact on the risk of breast cancer in BRCA1 and BRCA2 mutation carriers? (2015) (7)
- Examining Predictors of Fear of Cancer Recurrence Using Leventhal's Commonsense Model: Distinct Implications for Oncology Nurses. (2019) (7)
- Rapid Genetic Testing for BRCA1 and BRCA2 Mutations at the Time of Breast Cancer Diagnosis: An Observational Study (2020) (6)
- The Screen Project: Guided Direct-To-Consumer Genetic Testing for Breast Cancer Susceptibility in Canada (2021) (6)
- The impact of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers. (2014) (5)
- Understanding the role of oncogenic human papillomavirus (HPV) status on adherence behaviors among women with abnormal cervical cytology (2017) (5)
- Survival Differences in Women with and without Autologous Breast Reconstruction after Mastectomy for Breast Cancer (2017) (5)
- Predictors of the trajectory of cognitive functioning in the first 6 months after allogeneic hematopoietic stem cell transplantation (2019) (5)
- Abstract B7: Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation (2008) (5)
- Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers (2013) (5)
- Breast deformity and reconstruction in Turner syndrome: A collection of case studies (2015) (5)
- Decision-making about antidepressant medication use in pregnancy: a comparison between women making the decision in the preconception period versus in pregnancy (2020) (5)
- Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol (2018) (4)
- Breast Cancer Genetics for Plastic Surgeons (2017) (4)
- Effects of a foot self-care educational intervention on improving footwear choices in those with type 2 diabetes at low risk of foot ulceration (2014) (4)
- Predictors of mammographic density among women with a strong family history of breast cancer (2019) (4)
- A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY study. (2020) (4)
- A Pan-Canadian Prospective Study of Young Women with Breast Cancer: The Rationale and Protocol Design for the RUBY Study. (2020) (4)
- Accuracy and precision of continuous non-invasive arterial pressure monitoring in critical care: A systematic review and meta-analysis. (2021) (4)
- PALB2 mutations in high-risk women with breast or ovarian cancer. (2017) (3)
- Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think? (2022) (3)
- Survival from breast cancer in women with a BRCA2 mutation by treatment (2021) (3)
- Identifying the top research priorities in postmastectomy breast cancer reconstruction: a James Lind Alliance priority setting partnership (2021) (3)
- Risk factors for psychological morbidity and the protective role of coping self-efficacy in young women with breast cancer early in diagnosis: a national multicentre cohort study (2022) (3)
- Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers (2021) (3)
- The relationship between the predicted risk of death and psychosocial functioning among women with early-stage breast cancer (2020) (3)
- Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers (2005) (3)
- Reply to ‘Mutations in RECQL are not associated with breast cancer risk in an Australian population’ (2018) (2)
- Development of a Patient Decision Aid for Older Women With Stage I Breast Cancer Considering Adjuvant Treatment Postlumpectomy (2012) (2)
- Abstract P2-09-09: Risk-reducing surgery and cancer-related distress among femaleBRCA1andBRCA2mutation carriers: (2016) (2)
- Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation (2020) (2)
- Role Incongruence and Psychological Stress Symptoms in Substitute Decision Makers of Intensive Care Patients. (2020) (2)
- Examining social media peer support and improving psychosocial outcomes for young women with breast cancer. (2021) (1)
- Treatment decision making and psychosocial outcomes associated with rapid genetic testing for BRCA1 and BRCA2 in women newly diagnosed with breast cancer. (2016) (1)
- Development of a decision aid for young canadians diagnosed with breast cancer who are at risk of infertility following cancer treatment. (2017) (1)
- Identification of patients at high risk of negative psychological consequences associated with BRCA1 mutation (2012) (1)
- Psychosocial outcomes following surgery in women with unilateral, nonhereditary breast cancer. (2020) (1)
- Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature (2022) (1)
- A Qualitative Study of the Everyday Impacts of Cognitive Difficulties After Stem Cell Transplantation. (2022) (1)
- Erratum to: Development and Evaluation of a Decision Aid for BRCA Carriers with Breast Cancer (2013) (1)
- Selected abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer (2009) (1)
- Impact of rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis on psychosocial functioning (2021) (1)
- Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective, Pan-Canadian Study of Young Women with Breast Cancer (2022) (1)
- Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’ (2014) (1)
- Bilateral Oophorectomy and the Risk of Breast Cancer in BRCA1 Mutation Carriers: a Reappraisal. (2022) (1)
- Genetic testing for young women with breast cancer. (2018) (1)
- The human papillomavirus vaccine: an oncology nursing issue. (2009) (1)
- Outcomes associated with rapid genetic testing for BRCA1 and BRCA2 at time of breast cancer diagnosis. (2019) (1)
- Reflex BRCA1 and BRCA2 tumour genetic testing for high-grade serous ovarian cancer: streamlined for clinicians but what do patients think? (2022) (1)
- Predictors of the Trajectory of Neurocognitive Functioning in the First Six Months after Allogeneic Hematopoietic Stem Cell Transplantation (2015) (1)
- Effects of A Foot Self-Care Educational Intervention on Improving Footwear in Patients with Type 2 Diabetes at Low Risk for Foot Ulceration (2014) (1)
- Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation (2020) (1)
- Oestrogen receptor status and survival in women with BRCA2-associated breast cancer (2019) (1)
- Impact of BRCA mutation test results in members of hereditary breast ovarian cancer (HBOC) families (2005) (0)
- ASO Author Reflections: Psychosocial Outcomes After Breast Cancer Treatment (2021) (0)
- Psychosocial outcomes following contralateral prophylactic mastectomy in women with unilateral, nonhereditary breast cancer (2020) (0)
- What Comes Next? A Cohort Profile of Women Who Have Undergone BRCA1 and BRCA2 Testing in Ontario, Canada (2019) (0)
- The risks of cancer in older women with BRCA pathogenic variants: How far have we come? (2022) (0)
- Impact of patient, tumour and treatment factors on psychosocial outcomes in invasive breast cancer. (2021) (0)
- Late cognitive outcomes among allogeneic stem cell transplant survivors: follow-up data from a 6-year longitudinal study (2020) (0)
- ASO Visual Abstract: Longitudinal Study of Psychosocial Outcomes Following Surgery in Women with Unilateral Nonhereditary Breast Cancer (2021) (0)
- 119. A Prospective Evaluation of Breast Cancer Patient Perception of the Physical Wellbeing of the Chest (2022) (0)
- Psychological and health behaviour outcomes following multi-gene panel testing for hereditary breast and ovarian cancer risk: a mini-review of the literature (2022) (0)
- Preparing to survive: Improving outcomes for young women with breast cancer (2022) (0)
- Abstract P4-03-11: Population-based survival outcomes of pure vs mixed invasive lobular breast carcinoma in Ontario, Canada (2023) (0)
- The CREATE Method for Expressing Continuous Outcome Data in Absolute Terms for Use in Patient Treatment Decision Aids (2015) (0)
- Abstract 189: Expressing Continuous Cardiovascular Outcome Data in Absolute Terms for use in Patient Treatment Decision Aids: Validation of a Proposed Method (2013) (0)
- Abstract B020: Does surgical procedure influence psychosocial outcomes after treatment in women with ductal carcinoma in situ? (2022) (0)
- Abstract 4212: Comparison of thirty-year population-based incidence rates of invasive lobular vs ductal vs mixed breast carcinoma in Ontario, Canada (2023) (0)
- Genetic testing women with newly diagnosed breast cancer: What criteria are the most predictive of a positive test? (2022) (0)
- Patient-reported outcomes associated with population-based Jewish genetic testing for BRCA1 and BRCA2. (2015) (0)
- 831: DECISION-MAKING AND ADVERSE PSYCHOLOGICAL OUTCOMES IN SUBSTITUTE DECISION-MAKERS IN THE ICU (2019) (0)
- Predicting the individual clinical benefit of prophylactic bilateral mastectomy and oophorectomy in BRCA carriers with breast cancer (2008) (0)
- MRI volumetric analysis of fibroglandular tissue to assess risk of the spared nipple in BRCA 1/2 patients who are considering prophylactic nipple-sparing mastectomy. (2013) (0)
- The development of a decision aid for breast cancer prevention in BRCA1 and BRCA2 mutation carriers. (2006) (0)
- Building the What Comes Next Cohort for BRCA1 and BRCA2 testing: a descriptive analysis (2021) (0)
- BRCA Self-Concept Scale (2016) (0)
- Correction to: Survival from breast cancer in women with a BRCA2 mutation by treatment (2023) (0)
- 8. Decision Regret in Breast Reconstruction Patients Following Preconsultation Education Group Intervention: A Randomized Controlled Trial (2022) (0)
- Reply to ‘Mutations in RECQL are not associated with breast cancer risk in an Australian population’ (2018) (0)
- Predictors of mammographic density among women with a strong family history of breast cancer (2019) (0)
- Interest of individuals from BRCA families to participate in research studies focused on male BRCA carriers (2013) (0)
- The risks of breast and ovarian cancer associated with the Ashkenazi Jewish founder allele BRCA2 6174delT (2021) (0)
- Prevalence of PALB2 mutations in the Creighton University breast cancer family registry. (2015) (0)
- International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation (2019) (0)
- Gynecologic Cancer Risk and Genetics: Informing an Ideal Model of Gynecologic Cancer Prevention (2022) (0)
- Abstract P5-03-07: Prevalence of Pathogenic Variants in Cancer Predisposition Genes in Women with Young Onset Breast Cancer (2023) (0)
- ASO Visual Abstract: Surgeon and Patient Reports of Fertility Preservation Referral and Uptake in a Prospective Pan-Canadian Study of Young Women with Breast Cancer (2022) (0)
- P5-15-03: Development of a Patient Decision Aid for Women 70 Years and Older with Stage I, Hormonally Sensitive, Breast Cancer Considering Adjuvant Treatment Post-Lumpectomy. (2011) (0)
- Abstract P3-08-08: Preferences for breast cancer risk reduction amongBRCA1andBRCA2mutation carriers: A discrete choice experiment (2017) (0)
- Feasibility, Acceptability and Effects of a Foot Self-Care Educational Intervention on Minor Foot Problems in Patients with Type 2 Diabetes at Low Risk for Foot Ulceration: A Pilot Study (2013) (0)
- Preconsultation Educational Group Intervention Can Address the Knowledge Gap in Postmastectomy Breast Reconstruction (2020) (0)
- Reply to D. Rayson et al (2010) (0)
- Patient‐reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high‐grade serous ovarian cancer (2022) (0)
- Supportive‐expressive group therapy for women with brca1/2mutations: Results of a phase II trial (2005) (0)
- Abstract B12: The effect of physical activity and body size on mammographic density in high-risk, BRCA mutation-negative women (2017) (0)
This paper list is powered by the following services:
Other Resources About Kelly Metcalfe
What Schools Are Affiliated With Kelly Metcalfe?
Kelly Metcalfe is affiliated with the following schools:
